Jennifer Harris, PharmD has over 20 years of oncology-focused experience including involvement with 20 IND programs and 2 NDA submissions. Her experience encompasses drug development planning, budgeting and management of oncology trials with particular expertise in first-time-in human (FTIH) through proof-of-concept (POC) trials. Dr. Harris’ has clinical experience at large academic research hospitals and the National Institutes of Health (NIH)/ National Cancer Institute (NCI) intramural research program. She has global oncology drug development experience within big pharma, midsize and emerging biotech and CRO experience monitoring and managing global clinical trials. Her experience also includes medical affairs as a medical science liaison and involvement with cooperative groups, investigator-initiated and registry trials. She is a contributing author on multiple publications and meeting abstracts and has demonstrated written and spoken communication skills including presentations to a variety of audiences including physicians, nurses, sales associates and lay persons.